1. Home
  2. WNEB vs SGHT Comparison

WNEB vs SGHT Comparison

Compare WNEB & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western New England Bancorp Inc.

WNEB

Western New England Bancorp Inc.

HOLD

Current Price

$13.77

Market Cap

264.8M

Sector

Finance

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$3.91

Market Cap

187.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WNEB
SGHT
Founded
1853
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
264.8M
187.4M
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
WNEB
SGHT
Price
$13.77
$3.91
Analyst Decision
Hold
Buy
Analyst Count
2
7
Target Price
$12.50
$9.08
AVG Volume (30 Days)
58.8K
235.0K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
2.02%
N/A
EPS Growth
33.93
28.16
EPS
0.75
N/A
Revenue
$44,000.00
$77,363,000.00
Revenue This Year
N/A
$11.67
Revenue Next Year
$5.61
$10.39
P/E Ratio
$18.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.41
$2.40
52 Week High
$14.52
$9.24

Technical Indicators

Market Signals
Indicator
WNEB
SGHT
Relative Strength Index (RSI) 64.99 50.63
Support Level $12.07 $3.29
Resistance Level $13.95 $4.29
Average True Range (ATR) 0.27 0.20
MACD 0.11 0.09
Stochastic Oscillator 81.78 81.04

Price Performance

Historical Comparison
WNEB
SGHT

About WNEB Western New England Bancorp Inc.

Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: